COVID-19 epidemic has varied spectrum of symptoms. With this study we aim to evaluate prevalence of Olfactory and Gustatory dysfunction in COVID-19 patients. To assess Olfactory and Gustatory dysfunction in COVID-19 Patients in Indian Population. Settings and Design: Prospective observational study. RT-PCR proven COVID-19 patients were enrolled in the study. Detailed history and olfactory function and Taste function were evaluated. Patient with symptoms of olfactory dysfunction were subjected to fill (sQOD-NS questionnaire). Re-evaluation was done weekly till the time of discharge. Analysis was done with Wilcoxon test with help of SPSS software. A total of 152 patients (Male-78, Female-74) completed the study after weekly evaluation. Olfactory and Gustatory dysfunction was seen in 28 (18.41%) and 20 (13.15%). Mean duration of symptoms was 2.4444 ± 0.352 days. Olfactory dysfunction was the first presenting symptom in 11 out of 152 patients (7.23%). Mean QD-NOS score in patients with Anosmia and Hyposmia (28 patients) was 11.4 ± 2.01 and 13.61 ± 2.82 at 1st evaluation, 20.3 ± 1.49 and 20.33 ± 1.57 at 7th day and 21 in both subgroups at 14th day follow up. Dysgeusia was noticed in 20/152 patients (13.15%). Recovery in olfactory dysfunction and Dysgeusia was complete in all patients. Olfactory and gustatory dysfunctions are significant part of clinical spectrum of COVID-19 disease In Indian Population.

Introduction:Langerhans cell histiocytosis is a rare multiorgan disorder, commonly seen in the pediatric age group. Commonest presentation of the disease involving the temporal bone is ear discharge. This entity is often underdiagnosed and the patient is treated with multiple courses of antibiotics which leads to delay in diagnosis and initiating apropriate treatment. Case report:We present case reports of 2 children who presented to us with this rare disease. The line of management followed is discussed briefly. Our aim is to increase awareness of this disease amongst otolaryngologists and pediatricians so that they can identify such cases in a timely manner. Conclusion:Langerhans cell histiocytosis can affect any age group but is commonly seen in children. It can involve any organ system but the temporal bone is involved in most cases. The differential diagnosis of this disease should be kept in mind for any patient presenting with chronic ear discharge that is not responding to the appropriate line of management.

Background: Studies showed olfactory disturbances in COVID patients. This has attracted focus of clinicians as an easy clinical screening tool in suspected population. Material and methods: 70 mild and moderate category COVID-19 RT-PCR positive patients, more than 10 years of age were tested on day of admission for olfaction with serial dilution of n-butanol and asked to grade severity of their olfactory dysfunction according to visual analogue score from 1-10. Results: Fatigue 42 (93.33%), sore throat 37 (82.22%), fever 36 (80%) and dyspnea 23 (51.11%) were the most common symptoms in moderate patients. Diabetes, hypertension and allergy were the three prominent risk factors. At time of admission, n-butanol diagnosed 20 patients having olfactory dysfunction compared to 11 by VAS. Patients tend to grade their dysfunction higher on VAS whereas the n-butanol test classified their olfactory dysfunction lower. Viral load and high CRP were not found to be significantly related with olfactory dysfunction. d-Dimer and LDH levels were found statistically associated with higher grading of olfactory dysfunction detected by n-butanol. Conclusion: The majority of cases developed hyposmia before they were admitted to hospital even before they realized that they were having hyposmia as revealed by n-butanol testing. We should go for objective tests of olfaction.

Objective: The aim of the study was to assess the outcome of nasal deformity correction using rhinopasty outcome evaluation (ROE) scale. Materials and methods:We conducted a prospective study of 30 patients with crooked nasal deformityin period 2008 to 2011 and assessed outcome with the help of ROE scale.Results: Preoperative mean ROE score was 34.15 ± 15.58. All 30 patients ROE score was less than 85 in preoperative period. Postoperative mean score was 86.50 ± 7.07 with a mean gain of 52.35. 21/30 patients (70%) had postoperative score of more than 85 (excellent). Conclusion:Rhinoplasty outcome evaluation scale is a useful subjective tool to assess the impact of deformity and outcome after surgery (patient's satisfaction).

Mucormycosis is an opportunistic fungal infection which was earlier seen only in immunocompromised patients. With the recent covid pandemic, there had been a drastic surge in cases of mucormycosis worldwide and especially in India. Here, we present an unusual case of biopsy proven invasive mandibular mucormycosis in a patient with chronic kidney disease and a history of COVID-19 infection. The patient was given low-dose amphotericin B and underwent surgical debridement with a successful outcome.